EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Spinal Cord Stimulation for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of High‐ and Low‐Frequency Modalities

Chengjiang Liu iD, Zidi Xu iD, Yifu Liang iD, Yujia Luo iD, Siyao Zheng iD, Zhikang Ye iD, Zhiying Feng iD

Pain Research and Management · 2026-01 · 2026 (1)

DOI: 10.1155/prm/9347376 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Pain Research and Management, online erschienen am 25.05.2026. Verfasst von Chengjiang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, zju.edu.cn. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Spinal Cord Stimulation, Pain Management. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 Science Research Fund of National Health Commission of China-Major Health & Technology Project of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To systematically evaluate the efficacy and safety of high‐frequency (HF‐SCS) and low‐frequency (LF‐SCS) spinal cord stimulation for painful diabetic neuropathy (PDN) and to qualitatively explore potential differences between HF‐SCS and LF‐SCS based on indirect comparisons.

Methods

A systematic review and meta‐analysis were conducted following PRISMA guidelines. We searched PubMed, Scopus, Embase, Web of Science, and the Cochrane Library for studies published between 2015 and 2024. Inclusion criteria included studies involving adult patients with PDN receiving either HF‐SCS or LF‐SCS. Eligible studies reported outcomes such as pain relief VAS, EQ‐5D, and adverse events. Data were analyzed using a random‐effects model. Pain intensity outcomes were converted to a 0–10 scale and pooled as mean differences (MDs). The EQ‐5D index was pooled as standardized mean differences (SMDs). Sensitivity and subgroup analyses were performed to assess heterogeneity.

Results

In total, 9 studies, including 416 participants, were eligible. Moderate certainty evidence suggests that both HF‐SCS and LF‐SCS significantly reduce pain in patients with PDN. In RCTs, SCS reduced pain at 6 months compared with best medical therapy (overall MD on a 0–10 scale: −3.95, 95% CI −5.57 to −2.33). In subgroup analyses, the HF‐SCS trial showed an MD of −5.20 (95% CI −5.79 to −4.61), and LF‐SCS trials showed a pooled MD of −3.22 (95% CI −4.37 to −2.07). Both treatments were associated with low adverse event rates.

Conclusion

Both HF‐SCS and LF‐SCS were associated with substantial reductions in pain intensity in patients with PDN compared with best medical therapy or baseline, although the overall certainty of evidence was at most moderate. Because no head‐to‐head trials directly comparing HF‐SCS and LF‐SCS in PDN were available, comparative effectiveness between modalities remains uncertain; however, these cross‐study differences should be interpreted cautiously because the modalities were not compared head‐to‐head. Improvements in EQ‐5D were modest and did not consistently exceed the prespecified minimal important difference, and both modalities showed low rates of mainly device‐related complications with few serious adverse events reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesSpinal Cord StimulationPain ManagementHumansPain Measurement

Stichwörter der Autor:innen

diabetic neuralgiadiabetic neuropathynerve painneuropathic painpainful diabetic neuropathyspinal cord stimulation

Autor:innen und Institutionen

  • Department of Pain Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China, zju.edu.cn.
  • Michael G. DeGroote National Pain Centre, McMaster University, Hamilton, Ontario, Canada, mcmaster.ca.

ORCID-Profile: Chengjiang Liu, Zidi Xu, Yifu Liang, Yujia Luo, Siyao Zheng, Zhikang Ye, Zhiying Feng

Förderung

  • 2024 Science Research Fund of National Health Commission of China-Major Health & Technology Project of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, C., Xu, Z., Liang, Y., Luo, Y., Zheng, S., Ye, Z., & Feng, Z. (2026). Spinal Cord Stimulation for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of High‐ and Low‐Frequency Modalities. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/9347376

Vancouver

Liu C, Xu Z, Liang Y, Luo Y, Zheng S, Ye Z, et al. Spinal Cord Stimulation for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of High‐ and Low‐Frequency Modalities. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/9347376

BibTeX
@article{Liu2026,
  author = {Liu, Chengjiang and Xu, Zidi and Liang, Yifu and Luo, Yujia and Zheng, Siyao and Ye, Zhikang and Feng, Zhiying},
  title = {Spinal Cord Stimulation for Painful Diabetic Neuropathy: A Systematic Review and Meta‐Analysis of High‐ and Low‐Frequency Modalities},
  journal = {Pain Research and Management},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/prm/9347376}
}
Kostenlos starten →